Novel Coronavirus (SARS-CoV-2/COVID-19)
Join us to hear University of Chicago Medicine’s perspective from its medical laboratory as it forged and strengthened a network of support within its health system and across the community it served. Kathleen G. Beavis, MD, FCAP, medical director of University of Chicago Medicine’s microbiology…
The Department of Health and Human Services (HHS) today issued two important clarifications related to Provider Relief Fund (PRF) reporting.
This document requests action to spur Congress to fully reinstate June reporting requirements for the COVID-19 Provider Relief Fund during its ‘lame-duck session.’
This document requests action to spur Congress to fully reinstate June reporting requirements for the COVID-19 Provider Relief Fund during its ‘lame-duck session.’
Dr. Estes is joined by Kevin W. Sowers, President of the Johns Hopkins Health System and Executive Vice President of Johns Hopkins Medicine, to discuss how hospitals can move from relief, recovery, and rebuilding to reimagining and innovation.
The spread of COVID-19 revealed systemic cracks in the social needs and public health infrastructure of communities — inequities that have existed for decades. A Kaiser Permanente survey of 2,900 of its members earlier this year illustrates the disproportionate impact the pandemic is having on the…
The Food and Drug Administration issued final guidance for health care providers and researchers using investigational COVID-19 convalescent plasma, defined as convalescent plasma that does not meet all conditions of the agency’s emergency use authorization or which is used under an investigational…
The Department of Health and Human Services has released a PPE Preservation Planning Toolkit to help organizations implement strategies to preserve personal protective equipment during the COVID-19 pandemic.
The AHA, American Medical Association and American Nurses Association urged the Trump administration to share all critical information related to COVID-19 with the Biden transition team.
An AHA Member Call on Allocation and Distribution of Operation Warp Speed (OWS) Therapeutics with Nancy Foster and John Redd, MD, CMO, ASPR, including remdesivir and monoclonal antibody (MAB) therapeutics like bamlanivimab through the Emergency Use Authorization (EUA).